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ABSTRACT 
 
Stinson, Jelynn A., Biomedical Sciences Ph.D. Program, Wright State University, 
2012. Applications of Capillary Electrophoresis for Studying Serum Albumin 
Enantioselection of D,L-Tryptophan Analogs. 
  
  The pharmacokinetic difference between drug enantiomers is the impetus for 
developing analytical techniques to assess enantiomeric purity. Capillary 
electrophoresis (CE) is an analytical technique that is used for characterizing drug-
protein binding.  The pitfall to using CE for drug-protein binding studies is protein 
chiral selectors tend to adsorb onto capillary walls and cause changes in 
electroosmotic flow that lead to decreased enantioselection and migration time 
irreproducibility between consecutive injections. The experimental parameters for 
minimizing the adverse effects of protein adsorption are not clear from the literature.  
  Rinsing protocols to improve enantioselection and migration time repeatability 
were developed using the tryptophan-bovine serum albumin system as a model. The 
enantioselection of bovine serum albumin (BSA) could be improved by: 1) 
increasing separation voltage; 2) using sample buffer ionic strength at least 3 orders 
of magnitude less than the separation buffer; 3) limiting the equilibration time with 
separation buffer; and 4) allowing for protein diffusion. Rinsing the capillary with 
sodium hydroxide, followed by water improved migration time repeatability RSD 
from 24.7%  to 1.8% (n = 4).    
                                                                           iv 
  Drug-protein binding is contingent upon the three dimensional structure of the 
binding site, and the presence of other competing drug molecules. Drug-drug 
displacement is difficult to predict and the effects of protein glycation on binding of 
drugs is not well defined. To highlight the use of CE for addressing questions of 
biochemical interest, CE was applied to characterize drug-drug displacement and the 
effects of protein glycation on the enantioselection of drugs by BSA. The tryptophan-
bovine serum albumin, 5-fluoro-tryptophan-bovine serum albumin, and 5-hydroxy-
tryptophan-bovine serum albumin systems were used as models. 
  A CE method for studying competitive binding was established using ibuprofen 
as the displacer molecule. Accurate calculation of selectivity was found to depend on 
the precomplexation of ibuprofen and BSA.   A CE method for studying the effects 
of protein glycation was developed using BSA containing different degrees of 
glycation as chiral selectors. The enantioselection of tryptophan analogs by BSA was 
altered by glycation as reported in other analytical methods.  These studies can serve 
as guidelines for optimizing serum albumin enantioselection and extending its use in 
other biopharmaceutical applications.  
 
                                                                           v 
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Chapter 1 
 
General Introduction 
 
1.1. Background 
 
 Although the majority of active pharmaceutical ingredients (API) are marketed as 
racemates, typically only one isomer is pharmacologically active resulting in 
decreased therapeutic efficacy of the formulated product. Likewise, dissimilar 
properties of enantiomers can result in side effects that range from mild to deadly. 
Because of these problems, there has been increasing demand for the production of 
enantiomerically pure drugs by government agencies like the US Food and Drug 
Administration (FDA). In order to assure the quality of these products there has been 
increasing demand for reliable analytical methodology to assess enantiomeric purity 
(Núñez, et al., 2009).  It is this latter need that is the basis of the current work, which 
is concerned with the characterization and optimization of serum albumin as a chiral 
selector for carrying out enantiomeric separation by capillary electrophoresis.  Unlike 
other standard methods, capillary electrophoresis (CE) does not require the use of 
pure enantiomers, which makes it easy to carry out experiments under various 
conditions.   
 One of the major challenges to using a protein as a chiral selector is it has a 
tendency to adsorb onto the inner walls of the bare-fused capillaries used in this 
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technique. In this case, drug molecules will interact not only with the protein in the 
background electrolyte (BGE), but also with that adsorbed to the capillary wall. 
Adsorbed protein has been reported to cause fluctuations of electroosmotic flow 
(EOF).   This leads to peak shape distortion like tailing and band broadening that 
adversely affects resolution and efficiency (Ventura, et al., 2012). There is limited 
information available in the literature pertaining to the experimental conditions that 
are most relevant for improving chiral recognition of drugs by proteins.  Capillary 
rinsing strategies and adjustment of separation voltage have been reported to improve 
separation (Sokoliess & Koller, 2005; Ribeiro, et al., 2011). The presence of protein 
in the BGE presents a background absorbance that suppresses the sample signal if the 
protein concentration is too high and detection is at a wavelength where the protein 
absorbs strongly.   
 Tryptophan, one of the compounds used to carry out the CE chiral recognition 
studies, is an amino acid that exists as both D- and L-stereoisomers. The D-and L- 
structures, and two other tryptophan analogs used in the current study are shown in 
Figure 1.  Since tryptophan is a chemical precursor to the biosynthesis of serotonin, it 
along with its analogs, are administered for treatment of diseases where there is 
impaired synthesis of serotonin (Muck-Seler & Pivac, 2011).  Tryptophan is used as 
an additive in over the counter antidepressants, appetite suppressors, and in sleep aid 
products (Doghramiji, P., 2006; Robinson et. al, 2012). Tryptophan and its analogs 
also are administered in the treatment and diagnosis in more serious diseases such as 
carcinoid tumor metastases, migraines, and attention-deficit/hyperactivity disorder 
(Nikolaou, et.al., 2010; Johansson, et. al, 2011; Niederhofer, 2011).  
 3
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1:  Tryptophan and analogs : 5-fluoro-tryptophan; 5-hydroxy-tryptophan. 
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 Despite the advances made in stereoselective synthesis, the direct enantiomeric 
synthesis of drugs may be expensive and not always achievable (Ye, 2011).  For the 
analogs investigated in this work, a single step synthesis has been reported for 5-
fluorotryptophan (Winn et al., 2008). There are a number of established techniques in 
the pharmaceutical field used for stereoselective analysis (Christodoulou, 2010).  Of 
these, chiral separations performed using high pressure liquid chromatography 
(HPLC) continues to be the preferred approach (Wong et al., 2008; McConnell et al., 
2007; Núñez, et al., 2009). Enantiomers are separated in HPLC either indirectly with 
chiral derivatization reagents or directly with chiral stationary phases (CSPs). The 
most important protein-based CSPs used in HPLC are based on human serum 
albumin (HSA), α1-acid glycoprotein (AGP), crude ovumocoid (OVM) and 
cellobiohydrolase I (Lammerhofer, 2010).  The AGP CSPs have been used in the 
enantioseparation of D,L-penicillamine, D,L-cysteine, and β2 agonist, formoterol 
(Bhushan & Kumar, 2009; Akapo et al., 2009).  Work has been carried out in our lab 
to develop methods using immobilized human serum albumin, bovine serum albumin 
(BSA), sheep albumin, and pig albumin in the enantioseparation of D,L-tryptophan 
(Tittelbach & Gilpin, 1995). Bovine serum albumin-gold conjugates as stationary 
phase have been described for use in chip-based enantioselective capillary 
electrochromatography (Li et al., 2009). Recently, HPLC has been combined with 
nuclear magnetic resonance (NMR) to screen the chromatographic enantiorecognition 
process on CSPs as well as to determine the absolute configuration of enantiomers 
(Uccello-Barretta et al., 2010; Cirilli et al., 2010; Thompson et al., 2009).    
 6
 Other methods used for chiral separations include super-critical fluid 
chromatography, and preparative and simulated moving bed chromatography 
(Speybrouck et al., 2012; Zhang et al., 2012; Guiochon & Tarafder, 2011; Hsu et al., 
2011).  Spectroscopic techniques such as NMR provide a clear view of the binding 
mechanisms; however they have a high sample consumption rate (Oravcova et al., 
1996; Liu et al., 2008; Mathur et al., 2007).  Chromatographic assays also require the 
immobilization of the protein on a support, which alter the binding properties of the 
protein (Ascoli et al., 2006; Hage et al., 2009).  The cost efficiency and 
environmental aspects of CE, such as the use of very small volumes of sample and 
buffer solutions, along with short analysis time, and ease of automation make it 
advantageous over other methods.  Capillary electrophoresis has become a powerful 
tool for the separation of chiral drugs and biomolecules as reviewed by a number of 
publications on this topic (Altria & Elder, 2004; Natishan, 2005; Smith & Evans, 
1994; Lu & Guonan, 2010; Liu et al., 2008). The first use of CE for chiral separation 
was demonstrated in 1985 by Zare and co-workers, who resolved racemic mixtures of 
dansylated amino acids (Gassmann et al., 1985). 
 7
 
 
 
 
 
 
 
 
 
 
Figure 2:  Schematic of a Capillary Electrophoresis Instrument. 
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Figure 2. 
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1.2. Principles of separation in capillary electrophoresis  
 Capillary electrophoresis is a highly sensitive and selective method that separates 
components based on solute velocity in an electric field. The direction of movement 
is determined by the charge on the species, and the velocity is determined by the 
electrosmotic flow (EOF), electric field strength, shape of the solute, and ionic 
mobility. A general schematic of a capillary electrophoresis instrument is presented in 
Figure 2. Present commercially available systems also have a thermostatting system 
for temperature control.  
 Capillary electrophoretic separations are performed by first filling the capillary 
with an appropriate background electrolyte (BGE). A sample plug is then drawn into 
the capillary inlet by hydrodynamic or electrokinetic means.  Both the cathode and 
the anode are submerged in vials containing the BGE, and a voltage is applied to the 
system.   Solutes in the sample plug migrate along the capillary separating into zones 
according to their electrophoretic mobilites that are determined by their mass to 
charge ratio differences. 
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1.2.1.  Electrophoretic Mobility 
 When a separation voltage is applied, an electric field E (V/L) (where V is the 
voltage and L is the length of the capillary), develops along the length of the 
capillary.  Under the influence of this electric field, ionic species with charge q 
experience an electrostatic force  eF , 
                                                       qEeF                                                    (1)   
and a counteracting frictional force  frF  described mathematically by Stokes Law as:  
                                                        r6Ffr                                              (2) 
where η is the viscosity of the background electrolyte,   is the migration velocity, 
and r is the Stokes’ radius of the solute. During electrophoretic separation these 
forces are equal in magnitude setting up a steady state in which ionic species travel at 
a constant velocity. 
The velocity is a product of the electrophoretic mobility an  and the applied electric 
field 
                                                     Ean                                                  (3) 
The electrophoretic mobility for a charged species is approximated as  
                                                      r
q
 6an                                            (4) 
The mobility can be experimentally determined from the migration time (t) of the 
solute using the following equation:  
                                                       Et
l                                                   (5) 
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From equation 4, larger solutes with smaller charges will have a lower mobility than 
smaller solutes with greater charge.  Adjustments to the BGE’s pH can affect the 
overall charge of the ionic species causing their mobility to increase or decrease 
accordingly. Along with this, the addition of buffer additives or change in separation 
temperature will affect the viscosity of the BGE resulting in changes to 
electrophoretic mobility.   
1.2.2.  Electroosmotic flow 
 Movement of solutes within the capillary is not limited to charged molecules. 
Neutral solutes migrate within the capillary as the result of the electroosmotic flow. 
When the capillary is filled with BGE, a charge develops on the inside wall of the 
capillary. By electrostatic attraction, counterions in the BGE absorb on the wall 
setting up a double electric layer at the capillary wall-BGE interface.  According to a 
model proposed by Stern, the double layer is composed of a compact layer of tightly 
held ions and a diffuse layer (Giddings, 1969). 
 12
 
 
 
 
 
 
 
 
 
 
Figure 3:  Simplistic model of a double electric layer. 
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Figure 3. 
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 The electrical potential decreases with increasing distance from the capillary wall. 
The potential in the diffuse layer is referred to as the zeta potential (ζ).  An imaginary 
boundary is present between these layers called the plane of shear Figure 3. As a 
result of viscous drag, when an electric field is applied, ions in the diffuse layer break 
away at the plane of shear, dragging with them the bulk liquid producing an 
electroosmotic flow.  It is by EOF that neutral molecules are able to migrate. The 
mobility of the EOF is described by: 
                                                 



4
E
EOF                                                   (6) 
where EOF mobility is directly proportional to the dielectric constant of the solution 
(ε), the applied electrical field (E), and the zeta potential (ζ)  and inversely 
proportional to the viscosity of the BGE (η).  If this parameter is not controlled it can 
lead to a decrease in separation (Bullock & Yuan, 1991). The apparent mobility of a 
charged solute is the sum of the EOF mobility (Eq. 6) and its ionic mobility (Eq. 4). 
The EOF mobility is measured experimentally using an uncharged solute. 
1.2.3. Selectivity and efficiency 
 Since the EOF affects the amount of time a solute spends in the capillary, 
separation efficiency, selectivity, and resolution are related to the direction and 
velocity of the EOF.   Unlike laminar flow in liquid chromatography, the 
electroosmotic flow has minimal effect on resistance to mass transfer. Therefore, the 
theoretical plate count in a capillary is much larger than that of a chromatography 
column of the same length. 
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 Diffusion occurs during the time t, it takes for a sample zone to travel from the 
point of injection to the point of detection.  The spatial variance  L2  of the zone is 
given by:  
                              V/DL2L 22                                                               (7) 
where D is the diffusion coefficient of the solute, L is the total length of the capillary, 
V is the applied voltage, and μ is the apparent electrophoretic mobility of the solute. 
The efficiency is expressed by the theoretical plate number (N),  
                                 
L
LN 2
2

                                                                   (8) 
By substituting Eq. (7) into Eq. (8)  
                                  D2
VN                                                                    (9) 
 It can be observed from Eq. (9), that: a) The efficiency can be improved by applying 
high voltages; b) Solutes with higher mobilities and low diffusion coefficients will 
produce higher plate counts.   
 The efficiency may be experimentally determined by: 
                                     22/1w/t54.5N                                                     (10) 
where t is the migration time and w1/2 the peak at half height. Equation (10) is correct 
only for Gaussian peaks. Selectivity is the thermodynamic measure of the differences 
in affinity of two ligands for binding to a substrate. The selectivity is given by: 
             )(
)(2
21
21
average 

                                             (11) 
where μ1  and μ2  are the observed electrophoretic mobilities of each ligand. 
Differences in physiochemical properties between solutes determine differences in 
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selectivity. The most important parameter for optimizing the selectivity of charged 
solutes is pH (Guan et al., 2012). 
1.2.4. Resolution 
 Resolution is a function of the selectivity (α), migration time (t), and the 
separation efficiency (N) (Jones et al., 1990). Resolution is defined according to 
selectivity and efficiency by: 
                        2/12/1
average
s N4
1N4
1R 






                                 (12) 
 In CE there are many sources that can have adverse effects on resolution.  
Electrodispersion occurs when the electric field strength is non-linear along the length 
of the capillary.  When the voltage drop along the capillary is not linear, samples 
travel along the capillary at different velocities causing peak dispersion to occur. A 
measurement for the extent of this dispersion is given by the baseline peak width 
( basew ),  
                                            4w base                                                         (13) 
where σ is the standard deviation. The resolution can be determined from the 
migration time (t) by: 
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s                                            (14) 
where w is the baseline width in time. Conductivity differences between the sample 
zone and surrounding buffer zones, lead to peak shape distortion.  The effects of 
electrodispersion are addressed by adjusting the BGE’s ionic strength, sample plug 
injection length, and sample concentration. 
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1.3. Capillary Electrophoresis for enantioselective analysis 
 In the experimental set-up chiral separation is induced by the addition of chiral 
selectors to the background electrolyte. Upon the application of voltage, enantiomers, 
D and L migrate within the capillary interacting with a chiral selector P, forming 
drug- selector complexes with equilibrium constants KD  and KL : 
DPPD DK               and            LPPL LK                                (15)         
Two enantiomers of a given chiral compound have identical electrophoretic 
mobilities in free solution.  The resolution of enantiomers is based upon interaction 
with the chiral selector. The “three-point interaction model” states that three points of 
interaction between the chiral selector and one of the enantiomers is required before 
discrimination by the selector is achieved as illustrated in Figure 4 (Davankov, 1998; 
Kitawaga & Otsuka, 2011). The molecular interaction between the selector and 
enantiomer involves coulomb forces, hydrogen bonding, steric hindrance, π-π 
interaction, ion-dipole, dipole-dipole, London dispersion, and dipole-induced dipole 
forces.  The strongest interaction occurs with the Coulomb force (Kitawaga & 
Otsuka, 2011). For separation to be achieved, there are conditions that must be 
satisfied: (1) The equilibrium constants for selector-solute binding must be different 
for the two enantiomers; (2) There must be significant amounts of both chiral selector 
and solute; (3) Equilibration of the enantiomer in and out of the selector, must be 
faster than the time scale of separation; (4) Mobilities of complexed and free drug 
must be different. The enantiomer in complex with the selector will migrate at a 
velocity different from the free enantiomer. This results in measurable differences in 
electrophoretic mobility between free and complexed drugs. 
 18
 
 
 
 
 
 
 
 
 
 
Figure 4: The three point interaction model.  Enantiomer (a) can interact only with 
two sites on the chiral selector, while its mirror image enantiomer (b) presents three 
groups that match three sites of the selector. 
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1.3.1. Common chiral selectors 
 
 The further development and use of novel chiral selectors are based upon cost, 
availability, solvent compatibility, and performance compared to established 
selectors.  Selectors commonly used in CE chiral separations include cyclodextrins, 
micelles, macrocylic antibiotics, and proteins.   
1.3.1.1. Cyclodextrins 
 The majority of chiral CE separations make use of cyclodextrins.  Cyclodextrins 
are nonreducing oligosaccharides obtained from enzymatic digestion of starch.  They 
are commonly found in the α-, β-, and γ-conformations, composed of 6, 7, and 8 α- 
(1-4)- linked glucopyranose units, respectively. The α- structure is represented 
schematically in Figure 5.  Cyclodextrins have hydrophobic internal cavities and 
polar groups are on the outside.  Drug molecules fit into these cavities forming 
inclusion complexes (Schmitt et al., 2002). Formation of inclusion complexes is 
influenced by the geometry and size of the drug molecules. 
 While hydrophobic interactions predominate in the formation of inclusion 
complexes, polar interactions also can occur along with hydrogen bonding and Van 
der Waals forces.  The advantages associated with the use of cyclodextrins are their 
water solubility, ionizability, UV transparency, and stability in solution (Ilisz et al., 
2009; Zhang et al., 2012).  UV transparency of cyclodextrins is advantageous for 
development of CE methods. 
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1.3.1.2. Micelles 
 Micelles are formed when amphiphilic molecules containing both strongly polar 
and strongly nonpolar groups, aggregate in aqueous solutions above their critical 
micellar concentration. Amphiphilic molecules are frequently composed of a long 
nonpolar alkyl chain as the hydrophobic group and a polar head group (charged or 
neutral) as schematically represented in Figure 6 for sodium dodecyl sulfate (SDS).  
The ionic function of the surfactant hydrates readily, whereas the hydrophobic tail is 
intrinsically insoluble.  In polar solvents, it is assumed that micelles are spherical in 
shape and oriented such that the polar groups are located on the outer zone and the 
alkyl groups constitute a hydrophobic core (Masci et al., 2012).  The separation 
principle in micellar CE represents a hybrid technique based upon both a partitioning 
mechanism and electrokinetic migration.  It is analogous to chromatography in that 
enantiomers are separated based upon residence time differences in the mobile 
(aqueous) phase and more stationary (micellar) phase. 
 Mostly anionic surface-active compounds like SDS have been used for the 
analysis of ionic and nonionic compounds (Lin et al., 2004).  Cationic surfactants 
have been employed for anionic and neutral compounds (Wu et al., 2001).  One 
important aspect to consider when using a cationic surfactant at high concentration is 
the direction of the electroosmotic flow is reversed. Since resolution is improved 
when chiral selector and EOF move in opposite directions, separation efficiency may 
be adversely affected if experimental methods are not modified to address changes in 
EOF. 
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Figure 5: Structure of α- cyclodextrin. 
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Figure 6: Schematic representation of the amphipathic molecule sodium dodecyl 
sulfate (SDS). 
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1.3.1.3. Macrocylic antibiotics 
 Macrocyclic antibiotics are a class of antibiotics used in therapy against infections 
caused by gram-negative and gram-positive bacteria.  Natural and semisynthetic 
macrocyclic antibiotics comprise a variety of structural types, which include peptides, 
glycopeptides, ansa compounds, and peptide-heterocycle conjugates.  A schematic of 
an ansa compound is represented in Figure 7. There are acidic, basic, and neutral 
types of antibiotics that differ in a number of physicochemical properties that 
determine their usefulness for chiral selection.  Macrocyclic antibiotics contain 
functionalities such as ester, hydroxyl, amide, primary amine and aromatic groups 
which are involved in intermolecular interactions with chiral molecules (Armstrong et 
al., 1994).  The chiral recognition in intermolecular interactions is maintained by 
stereogenic centers.   The numbers of stereogenic centers in the antibiotics vary, 
allowing them to have multiple interactions with chiral molecules. 
  Macrocyclic antibodies interact with chiral molecules by hydrogen bonding, π-π 
interactions, hydrophobic interaction, dipole-dipole, and ionic interactions 
(Armstrong& Nair, 1997; Ward & Oswald, 1997).  The selectivity of macrocyclic 
antibiotics is specific to the charge of the analyte and especially useful for the 
separation of acidic chiral analytes. Macrocyclic antibiotics use for the determination 
of trace levels of chiral compounds can be hindered by their high UV absorbance. 
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Figure. 7:  Schematic of an ansa compound.  (n ≥ 5)*  Where n denotes the number of 
atoms bridging the para positions on the molecule. 
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1.3.1.4. Proteins  
 Proteins are high molecular weight biopolymers which consist of L-amino acids. 
Many uniquely bind a single enantiomer of chiral molecules. Protein chiral 
recognition is affected by both charge and hydrophobic interactions.  This mode of 
CE, utilizing protein as the chiral selector is referred to as affinity capillary 
electrophoresis (ACE).  There are a number of proteins that have been used to carry 
out chiral CE separations.  Examples include glycoproteins, enzymes such as 
lysozyme, fungal cellulase, as well as cytochrome c (Tanaka & Terabe, 2001). Alpha 
(1) acid glycoprotein is one of many glycoproteins found in plasma that is responsible 
for the binding of cationic drugs (Li & Lloyd, 1993; Tanaka & Terabe, 1997; Amini 
et al., 1997).  The enantioselective binding of drugs is influenced by sugar moities 
and sialic acid residues.  In the case of enzymes, the enzymatically active core is the 
dominating site for drug binding (Marle et al., 1993).  Although a number of proteins 
have been employed, the most extensively studied in chiral CE are bovine serum 
albumin and human serum albumin.   
1.3.1.4.1. Drug-serum albumin binding 
 The first study aimed at examining the suitability of CE applications for 
measuring drug-plasma protein binding was reported in 1992 (Kraak et al., 1992). 
Serum albumin is the most abundant protein in plasma (Fanali, et al., 2012).  Bovine 
serum albumin (BSA) consists of a single polypeptide chain of 581 amino acid 
residues that are folded in a series of α-helices, and further organized into three 
domains.  The tertiary structure of BSA is stabilized by 17 disulfide bridges. The 
warafin-azapropazone site (site I) and the indol-benzodiazepine site (site II) are the 
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two major sites in serum albumin for binding drugs (Sudlow, et al., 1976).  Figure 8 
shows the structure of albumin with different binding sites based upon Protein Data 
Bank file, 2BXG.  Although both site I and II have been reported to bind aromatic 
and heterocyclic ligands site I tends to bind bulky heterocyclic anions (Peters, 1996; 
Carter & Ho, 1994). As a result of its ability to accommodate more than one ligand at 
a time, site I is described as a large and flexible region (Peters, 1996).  By contrast 
site II, is smaller, less flexible and more stereospecific binding occurs at this location. 
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Figure 8:   Albumin binding sites.  The structure of albumin is shown with the major 
drug binding sites labeled (PDB ID: 2BXG). 
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1.4. Factors that reduce tryptophan-serum albumin binding  
 It is accepted that the pharmacokinetic properties of drugs are influenced by 
reversible interactions with serum proteins (McMenamy & Oncley, 1958: Sudlow et 
al., 1975). Thus, the enantioselective binding of drugs by serum proteins is of great 
importance in the drug development process.  Drug enantiomers tend to have 
different binding affinities for proteins.  Drug binding constants provide quantitative 
measures by which drug binding and drug-drug displacement are determined and 
possible side effects are checked during preclinical trials (Betts et al., 2010, Rudnev 
et al., 2006).   
 In the presence of competing molecules, the extent of drug binding to serum 
proteins is reduced.  Site II in serum albumin, is the high affinity binding site for both 
L-tryptophan and the non-steroidal anti-inflammatory drug ibuprofen (Sun & Wang, 
2012). Ibuprofen and tryptophan are administered in the treatment of migraines.  As a 
result of limited binding sites for these drugs, if administered concurrently, 
competition will exist between ibuprofen and L-tryptophan for binding 
(Berezhkovskiy, 2006). Inhibition of binding by one drug to another is a function of 
the relative concentrations of each drug, and specificity of binding (Langlois et al., 
2012).  There are a number of secondary drug binding sites on serum proteins that 
make drug-drug displacement difficult to predict. Strategies to investigate the effects 
of ibuprofen on interactions of tryptophan with serum albumin prove vital for 
providing insight into the usefulness of certain drug combinations.  The displacement 
of L-tryptophan from serum albumin by ibuprofen has been studied by ultrafiltration 
and other in vitro assays (Basken et al., 2009).   
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 The ability of proteins to select between optical isomers is attributed to their three 
dimensional structure. When protein modification induced by physiological changes 
occurs, an alteration of the protein’s native binding efficiency is expected (Oettl & 
Stauber, 2007). Non-enzymatic glycation is a major in vivo mechanism that 
contributes to structural alteration of albumin.  Glycation occurs most often at the N-
terminal amino group and the side chains of the lysine residues. It also has been 
reported to occur at arginine, cysteine, histidine, and tryptophan residues (Munch et 
al., 1999).  Glycation of a lysine side chain occurs through the Maillard reaction as 
shown in Figure 9.  In the initial step of glycation, glucose attaches to free amine 
groups of albumin, forming a reversible Schiff base. Through an Amadori 
rearrangement a stable fructosamine product is formed. Schiff base and fructosamine 
products are the early glycation adducts which can be further modified by 
rearrangement, oxidation, polymerization, and cleavage to form irreversible 
conjugates called advanced glycation end products (Thornalley, 1999). 
 The extent of glycation is a function of glucose concentration and protein reaction 
time.  Associated with the extent of glycation is a change in protein mass and charge.  
Knowledge about how glycation effects drug binding may lead to advancement in 
both treatment and diagnosis of diseases such as diabetes.  Clinical implications of 
albumin glycation include drug binding may be altered for example at various stages 
of diabetes. In one study the binding of tryptophan by albumin, was found not to be 
affected by glycation, while in a different study low levels of glucose were reported 
to lower the affinity of albumin to bind (Bohney et al., 1992; Barzegar et al., 2007). 
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Figure 9:  Formation of glycated albumin. 
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 Studies to investigate the binding capacity of glycated albumin have been done 
using equilibrium dialysis, ultrafiltration, and high-performance liquid 
chromatography (Bohney & Feldhoff, 1991; Koizumi et al., 1998; Mikulikova et al., 
2005).  Disadvantages to using equilibrium dialysis are volume shifts, nonspecific 
adsorption to the dialysis apparatus, and Donan effects (Oravcova et al., 1996).  A 
pitfall to ultrafiltration is the necessity for a large number of data points. The 
problematic aspect of high pressure liquid chromatography is the high sample 
consumption rate. Contradictory reports have given impetus to further develop 
simplistic methods that can provide accurate information for characterizing the effects 
of serum albumin glycation on drug binding.   
 The use of CE as an analytical tool for addressing biochemical questions of 
interest is demonstrated in this dissertation by developing methods to characterize the 
effects of ibuprofen and glycation of BSA on the enantioselection of chiral drugs. 
 
1.5. HYPOTHESIS  
I hypothesize that capillary electrophoresis can be systematically optimized to 
develop experimental protocols and associated fundamental models for examining 
protein-drug binding and modulation of those interactions through drug-drug 
displacement and subtle changes in protein structure.  
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Chapter 2 
 
Materials and Methods 
 
2.1. Chemicals 
 
 Bovine serum albumin (cat. No. BP671-1), sodium phosphate dibasic (cat. No. 
5374-500), phosphoric acid (85%) (cat. No. 7664-38-2), methanol (cat. No. A452SK-
4), and sodium hydroxide (NaOH) (cat. No. 1310-73-2) were purchased from Fisher 
Scientific (Fair Lawn, NJ, USA); D,L-tryptophan (CAS: 54-12-6) was purchased 
from ACRŌS Organics (Fair Lawn, NJ, USA); Ibuprofen (cat. No. I-1892), 5-fluoro-
D,L-tryptophan (cat. No. 154-08-5), deuterium oxide (D2O) (cat. No. 7789-20-0), and 
5-hydroxy-D,L-tryptophan (cat. No. 114-03-4) were purchased from Sigma Aldrich 
(St. Louis, MO, USA). Sodium phosphate monobasic (cat. No. 4011-1) was 
purchased from J.T. Baker, Inc. (Phillipsburg, NJ, USA). D- (+)-glucose (cat. 
No.194672) was purchased from MP Biomedicals, LLC (Solon, OH, USA). Solutions 
were prepared in deionized water treated using a Water PRO Plus system by 
LABCONCO (LABCONCO Corp, Kansas City, MO, USA).    
2.2. Instrumentation  
 
2.2.1. Capillary electrophoresis (CE) 
 
 An Agilent G1600 HP3D Core CE system (Santa Clara, CA, USA) was employed 
for separations. Data acquisition and instrument control were by ChemStation 
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software (Agilent, Waldbronn, Germany). Data were exported to Excel (Microsoft, 
Redmond, WA, USA) and then further mathematically processed using SigmaPlot 12 
 (Systat Software, Inc., San Jose, CA, USA) and BOMEM GRAMS/386 software 
(ABB Bomem Inc., Québec, Canada) for curve fitting.  The separations were 
performed in bare fused-silica capillaries (cat. No. G1600-60311) purchased from 
Agilent with 48.5 cm total lengths, effective lengths of 40 cm, and internal diameters 
of 75µm.  New capillaries were rinsed with NaOH (0.3 M) for 30 min, and deionized 
water for 30 min, then background electrolyte for 60 min at 920 mbar. When not in 
use, capillaries were rinsed with 0.1 M NaOH for 10 minutes, water for 10 minutes, 
air for 20 minutes, and stored dry. The capillary temperature was maintained at 
C25 throughout separations. Samples were injected hydrodynamically using 20 mbar 
pressure for 5 seconds. 
2.2.2. Mass Spectrometer 
 Mass spectra were acquired on a Bio-TOF III high resolution mass spectrometer 
(Bruker Daltonics, Billerica, MA, USA).  Data was acquired by DataAnalysis 3.2 
software (Bruker Daltonics, Billerica, MA, USA).  Samples were injected into the 
mass spectrometer using a Cole Palmer syringe pump (cat. No.74900-05, Vernon 
Hill, IL, USA).  
2.2.3. Proton Nuclear magnetic resonance 
 A Varian INOVA 600 NMR spectrometer (Palo Alto, CA, USA)  equipped with : 
(1) a triple resonance inverse probe (1H/13C/X), (2) a broadband observe probe with 
a 13C/1Hdecouple channel (X/13C/1H), (3) an inverse nanoprobe for 1H MAS 
spectroscopy in small volumes (40 μl), (4) a variable temperature unit (FTS Systems, 
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XR401 air-jet crystal cooler, C40 to + C100 , and (5) a Zymark XP robotics 
sample changer. 
2.3. Determine relevant parameters for improving enantioselection         
 and migration time reproducibility 
 
 Consecutive runs were made of D,L tryptophan (0.5 mg/ml), chosen arbitrarily for 
simplicity, in the presence of 30 μM BSA. Previous studies aimed at assessing 
enantioselection of tryptophan enantiomers reported optimized resolution occurs 
when there is a concentration of 30 μM BSA in the background electrolyte (Hödl et 
al., 2006). Buffer concentration and temperature listed as optimal for BSA binding 
employed in HPLC separations were 25 mM sodium phosphate, pH 7.4 at 25°C 
(Gilpin et al., 1991). As a result of these findings, initial experiments were carried out 
under these conditions. The tryptophan-BSA model was used in this study.  Four 
separate preconditioning experiments were carried out to investigate the effects of 
protein adsorption on enantioselection.  
2.3.1. Ohm’s Law plot  
 To assure joule heating would be minimized, an Ohm’s Law plot was constructed 
to determine the buffering capacities of 25 mM, 50 mM, 75mM, and 100 mM sodium 
phosphate buffer systems before serum protein addition.   
Solution preparation 
 A concentrated 0.1 M sodium phosphate buffer was prepared by placing 2.62 g of 
sodium phosphate monobasic, and 14.42 g sodium phosphate dibasic into a 1L 
volumetric flask.  To the flask 800 ml of water was added, pH of solution was 
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adjusted to 7.4 using phosphoric acid (85%), then additional water was added to bring 
final volume to 1 L.  The 25 mM, 50 mM, and 75 mM sodium phosphate buffers were 
prepared by pipeting 3.75 ml, 7.5 ml, and 11.25 ml of the 0.1 M buffer into separate 
volumetric flask, respectively. Each solution was brought to a final volume of 15 ml 
with deionized water. Prior to use, buffers were degassed by mixing with a magnetic 
stir bar while under vacuum. They were also filtered through a Fisherbrand 0.20 μm 
pore size, PTFE filter (Fisher Scientific, Fair Lawn, NJ, USA).  Sodium hydroxide 
(0.1M) was prepared in deionized water. It was also degassed by stirring and vacuum 
suction.  
CE instrumental set-up 
 The instrument settings were as follows:  CE MODE, CE; INJECTION BY, No 
Injection; Lift Offset: 4 mm, Cassette Temperature, 25°C; CE Conditioning: 
Replenish (none), Postconditioning (none), Preconditioning (Use Table);  Diode 
Array Detector (DAD) Signals: A- 200, B-240, C-260, D- 270, E- 280, and spectrum 
store- All in peak, with a threshold of 2.00 mAu; Time Table tab checked voltage, 
current, and temperature with a stoptime of 0.20 min; Switch Electric was set to on 
with a positive polarity and a voltage ramp of 0 to 30 kV was applied.  At the 
capillary inlet were vials containing 1 ml of NaOH (0.1M), deionized water, and 
sodium phosphate buffer (25 mM - 100 mM). At the capillary outlet were vials 
containing 1 ml of sodium phosphate buffers (25 mM -100 mM), deionized water, 
and an empty vial for waste. 
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Separation method and data acquisition  
 The following steps were used for constructing the Ohm’s plot for each buffer 
system tested: 1) Rinsed capillary 1 minute with NaOH (0.1M) with an applied 
pressure of 50.0 mbar; 2) Waited 4 minutes; 3) Rinsed capillary 1 minute with water  
with an applied pressure of 50.0 mbar; 4) Rinsed the capillary 1 minute with sodium 
phosphate buffer with an applied pressure of 50.0 mbar; 5) Switched on voltage for 
2.5 minutes with a ramping time of 1 minute; 6) Recorded the current and voltage.  
Data processing 
 Current and voltage signals were exported as CSV files to Excel (Microsoft, 
Redmond, WA, USA).   The buffering capacity was evaluated by plotting the current 
as a function of applied voltage.   
2.3.2. Applied voltage effects on peak shape   
Solution preparation 
 The background electrolyte, 25 mM sodium phosphate containing 30 μM BSA, 
pH 7.4, was prepared from a 0.1 M concentrated solution. The 0.1 M concentrated 
sodium phosphate solution and 0.1M NaOH were prepared as described in section 
2.3.1. The BGE was prepared as follows: 1) Added 0.1188 g of BSA to 15 ml of  
0.1 M sodium phosphate buffer, pH 7.4; 2) Removed 3.75 ml of the BSA solution and 
placed it into a volumetric flask. 3) Diluted the solution to a final volume of 15 ml 
with deionized water.  Samples were prepared by dissolving D,L-tryptophan in 
deionized water (0.5 mg/ml). The sample plug volume in the capillary was 17.97 nl. 
The total capillary volume was 2143 nl.  The mole ratio of drug:BSA in the capillary 
interacting was 1:2. Prior to use, buffers and samples were degassed by mixing with a 
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magnetic stir bar while under vacuum. Buffers and samples were filtered through a 
Fisherbrand 0.20 μm pore size, PTFE filter (Fisher Scientific, Fair Lawn, NJ, USA).  
CE instrumental set-up 
 The instrument settings were as follows:  CE MODE, CE; INJECTION BY, 
Pressure 20 mbar for 5 seconds; Lift Offset: 4 mm, Cassette Temperature, 25°C;  
CE Conditioning: Replenish (none), Postconditioning (none), Preconditioning (Use 
Table) table set-up is described in the next section below ;  DAD Signals: A- 191, B-
200, C-254, D- 270, E- 280, and spectrum store- All in peak, with a threshold of 2.00 
mAu; Time Table tab checked voltage, current, and temperature with a stop time of 
30.0 min; Switch Electric was set to on with a positive polarity, constant voltages of 
10 kV  to 30 kV were applied.   
Separation method and data acquisition 
 To test applied voltage, the CE preconditioning table was configured as follows: 
1. FLUSH 3.00 min with NaOH (0.1 M); 2. FLUSH 3.00 min with water; 3. FLUSH 
8 min with BGE.  The outlet vials for all flushing steps were empty waste vials.  
Following preconditioning of the capillaries surface, a constant separation voltage of 
10 kV to 30 kV was applied over a 30 minute separation. The migration time of 
enantiomers was recorded at each voltage. 
Data processing 
 The 280 nm signal was exported as a CSV file to Excel (Microsoft, Redmond, 
WA, USA).   The mobility determined from enantiomer migration time and applied 
voltage, as described in equation 5. The mobility of analyte was determined first in 
BGE void of BSA. The viscosity of the BGE changed upon the addition of BSA. To 
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account for changes in BGE viscosity associated with the addition of protein, a 
corrected migration time, EOFdrug tt  , where  drugt  and EOFt  is the migration time of 
the enantiomer and EOF, respectively, was used to create the plot. 
To redraw electropharograms, corrected data were saved as text delimited files and 
exported to BOMEM GRAMS/386 program for curve fitting. The selectivity was 
measured for both enantiomers at each applied voltage. The difference in selectivity 
as a function of voltage was plotted.  
2.3.3. Sodium hydroxide and water rinse effects on migration time   
 
Solution preparations 
 The BGE was prepared as described in 2.3.2.  The sodium hydroxide was 
prepared as described in 2.3.1. 
CE instrumental set-up 
 The CE instrumental set-up was as described in 2.3.2. with the following 
modifications: 1) Switch electric was set to on with a positive polarity voltage of 15 
kV; 2) preconditioning table set-up is described in the next section below.  
Separation method and data acquisition 
 To test sodium hydroxide -water rinse times, the CE preconditioning table was 
initially  configured as follows: 1) FLUSH 3.00 min with NaOH (0.1 M); 2) FLUSH 
3.00 min with deionized water; 3) FLUSH 8 min with BGE.  Flush times with NaOH 
(0.1 M) and water were increased by an increment of 3 min every fourth injection, to 
a final rinse time of 15 min. The outlet vials for all flushing steps were empty waste 
vials.  Following preconditioning of the capillaries surface, a separation voltage of  
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15 kV was applied for 30 minutes. The migration times of enantiomers and acetone (n 
= 4) were recorded.  
Data processing 
 The 280 nm signal was exported as a CSV file to Excel (Microsoft, Redmond, 
WA, USA).   Fluctuation in migration time associated with change in BGE viscosity 
was corrected by subtracting the migration time of acetone. The difference in 
migration time of acetone as a function of NaOH/water rinse time between 
consecutive injections (n =4) was measured.  
2.3.4. Evaluating the selectivity as a function of BGE rinse time  
Solution preparations 
 The BGE and samples were prepared as described in 2.3.2.  The sodium 
hydroxide was prepared as described in 2.3.1. 
CE instrumental set-up 
 The CE instrumental set-up was as described in 2.3.2. with the following 
modifications: 1)Switch electric was set to on with a positive polarity voltage of 15 
kV; 2)preconditioning table set-up is described in the next section below.  
Separation method and data acquisition 
 To test BGE rinse times, the CE Preconditioning table was initially configured as 
follows: 1) FLUSH 3.00 min with NaOH (0.1 M); 2) FLUSH 3.00 min with 
deionized water; 3) FLUSH 8 min with BGE.  Flush times with BGE were increased 
by an increment of 8 min every fourth injection, to a final rinse time of 32 min. The 
outlet vials for all flushing steps were empty waste vials.  Following preconditioning 
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of the capillaries surface, a separation voltage of 15 kV was applied for 30 minutes. 
The migration times of enantiomers and acetone (n = 4) were recorded.  
Data processing 
 Data was processed as described in 2.3.2. with the following modification: The 
change in the selectivity as a function of BGE rinse time was measured. 
2.3.5. Evaluating the selectivity as a function of wait time  
Solution preparations 
 The BGE and samples were prepared as described in 2.3.2.  The sodium 
hydroxide was prepared as described in 2.3.1.  
CE instrumental set-up 
 As described in 2.3.2. With the following modifications: Switch electric was set 
to on with a positive polarity voltage of 15 kV; preconditioning table set-up is 
described in the next section below. 
 Separation method and data acquisition 
 To test wait times, the CE Preconditioning table was initially configured as 
follows: 1) FLUSH 3.00 min with NaOH (0.1 M); 2) FLUSH 3.00 min with water; 3) 
FLUSH 8 min with BGE; 4) WAIT 10 min.  Wait times prior to separation voltage 
application were increased by an increment of 10 min every fourth injection, to a final 
wait time of 60 min. The outlet vials for all flushing steps were empty waste vials.  
Following preconditioning of the capillaries surface, a separation voltage of  
15 kV was applied for 30 minutes. The migration times of enantiomers and acetone (n 
= 4) were recorded.  
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Data processing 
 Data was processed as described in 2.3.2. with the following modification: The 
change in selectivity as a function of wait time was measured. 
2.3.6. Evaluating the selectivity as a function of sample buffer ionic strength  
Solution preparations 
 The BGE was prepared as described in 2.3.2.  The sodium hydroxide was 
prepared as described in 2.3.1.  Samples were prepared by dissolving tryptophan (0.5 
mg/ml) in sodium phosphate buffer, pH 7.4, of ionic strengths 5 mM to 25 mM. All 
buffers were prepared from 0.1 M concentrated buffer. Prior to use, buffers and 
samples were degassed by mixing with a magnetic stir bar while under vacuum. 
Buffers and samples were filtered through a Fisherbrand 0.20 μm pore size, PTFE 
filter (Fisher Scientific, Fair Lawn, NJ, USA).   
CE instrumental set-up 
 The CE instrumental set-up was as described in 2.3.2. with the following 
modifications: 1) Switch electric was set to on with a positive polarity voltage of 15 
kV; 2) preconditioning table set-up is described in the next section below.  
 Separation method and data acquisition  
 The CE Preconditioning table was configured as follows: 1. FLUSH 3.00 min to  
with NaOH (0.1 M); 2. FLUSH 3.00 min with water; 3. FLUSH 8 min with BGE; 4. 
WAIT 10 min.  The outlet vials for all flushing steps were empty waste vials.  
Following preconditioning of the capillaries surface, a separation voltage of 15 kV 
was applied for 30 minutes. The migration times of enantiomers and acetone (n = 4) 
were recorded.  
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Data processing 
 Data were processed as described in 2.3.2. With the following modification: The 
difference in selectivity as a function of sample buffer ionic strength was measured. 
2.4. Capillary electrophoresis applications for studying  
        competitive binding. 
 
 The displacement of L-tryptophan by ibuprofen can be determined by using 
ibuprofen as an additive to the BGE (Berezhkovskiy, 2006).  The influence of 
ibuprofen on the enantioselection of 5-fluoro-D,L-tryptophan and D,L-tryptophan by 
BSA was studied. The tryptophan-BSA model was employed. 
Solution preparations 
 
 For binding constant measurements BGEs containing 0, 10 μM, 15 μM , 20 μM, 
30 μM, and 35 μM  BSA were employed. The sodium phosphate 0.1M buffer was 
prepared as described in 2.3.1. To obtain the desired BSA molar concentrations, 
protein was added to 15 ml of 0.1M sodium phosphate, pH 7.4 as following: 10 μM, 
0.0396 g; 15 μM, 0.0594 g; 20 μM, 0.0792 g; 30 μM, 0.1188 g; and 35 μM, 0.1386 g. 
For competitive binding studies, ibuprofen solution was added to BGE (35 μM) at a 
concentration ranging from 0 to 55.3 μM.  Samples of D,L-tryptophan and 5-fluoro-
D,L-tryptophan (0.0225 to 0.54 (mg/ml)) in 8 mM sodium phosphate, pH 7.4. Prior to 
use, samples and buffers were degassed and filtered through a Fisherbrand 0.20 μm 
pore size, PTFE filter (cat. No. 09-720-7) (Fisher Scientific, Fair Lawn, NJ, USA).  
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CE instrumental set-up 
 The CE instrumental set-up was as described in 2.3.2. with the following 
modifications: 1) Switch electric was set to on with a positive polarity voltage of 15 
kV; 2) preconditioning table set-up is described in the next section below. 
Separation method and data acquisition 
 The CE Preconditioning table was configured as follows: 1) FLUSH 3.00 min 
with NaOH (0.1 M); 2) FLUSH 3.00 min with deionized water; 3) FLUSH 8 min 
with BGE; 4) WAIT 10 min.  The outlet vials for all flushing steps were empty waste 
vials.  Following preconditioning of the capillaries surface, a separation voltage of 15 
kV was applied for 30 minutes. The migration times of enantiomers and acetone (n = 
4) were recorded. 
Data processing 
 Data were processed as described in 2.3.2. with the following modification: The 
difference in selectivity as a function of ibuprofen concentration was measured.  
2.5. Capillary electrophoresis applications for studying binding  
       of glycated serum proteins. 
 
Solution preparations 
 
 The BGE for control and test experiments were prepared in both deionized water 
(H2O) and deuterium oxide (D2O) as described in 2.3.2. D-glucose (14.5 mM) was 
added to the test BGE. Samples were prepared as described in 2.3.2. The sodium 
hydroxide was prepared as described in 2.3.1.  A 50 ml methanol/water (80/20) 
solution containing 0.1% trifluoroacetic acid  (TFA) was prepared by placing 39.96 
ml methanol,  9.99 ml deionized water, and 50 μl TFA in a 50 ml volumetric flask. 
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The BGE employed for mass spectral analysis, was prepared as follows: 0.25 ml of 
BGE (H2O) was placed into a microcentrifuge tube and diluted with methanol/water 
solution to a final volume of 1.0 ml. 
Instrumental set-up 
Capillary Electrophoresis 
 The CE instrumental set-up was as described in 2.4.2.  
NMR  
 The instrument was set at the following: 1 H resonance frequency = 600 MHz; 
CPMG spin echo pulse sequence (Echo Time, TE = 30 msec). Measurements were 
taken at 25°C.  
Mass Spectrometry 
 The instrument settings were as follows:  ESI Ionization; Positive Polarity; 
Drying Gas Temperature 250°C; sample rate 2 GS/ s; delay time, 25 μs; Capillary, 4 
kV; End Plate, 3.5 kV; Cylinder, 2 kV; Digitizer Summing, 500 spectra. 
Separation method and data acquisition  
Capillary Electrophoresis 
Data were acquired as described in 2.4.3.  
NMR 
 Data were acquired over 8 hours using: 1.0 s Relax. Delay; pulse of 34.6 degrees; 
Acq. Time 4.0 sec; Width 8,000 Hz.   
Mass spectrometry 
 Mass spectra were recorded using 0.5 ml of BGE (H2O) injected from a 0.5 ml 
Gastight syringe (cat. No. 1750, Hamilton Co., Reno, NV, USA) using a flow rate of 
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100 μl/hr.   Mass spectrum was acquired by setting the Deconvoluted  parameters tab 
in the DataAnalysis 3.2 software (Bruker Daltonics, Billerica, MA, USA) to the 
following: Proteins/Large Molecules; Adduct ions (+H, -H); low mass, 1000 (m/z) 
and high mass, 100,000 (m/z); abundance cutoff, 10%; maximum charge, +75.   
Data processing 
Capillary Electrophoresis 
 Data were processed as described in 2.3.2. with the following modifications: The 
difference in selectivity as a function of glycation extent was measured.  
 NMR 
 Data were processed by the following parameters: Line broadening 0.3 Hz; FT 
size 65536. 
Mass Spectrometry 
 The number of glucose molecules was determined by the following steps: 1) A 
detailed deconvoluted mass was measured for unmodified BSA. Results were 
exported to Excel (Microsoft, Redmond, WA, USA) and externally calibrated by 
dividing the calculated mass by the literature reported mass for BSA (66.4 kD).  The 
quotient was used as the calibration constant. 2) The corrected deconvoluted masses 
for weeks 1 -3 were determined by dividing the experimentally determined masses for 
each by the calibration constant. 3) The mass difference between control BSA and 
that for weeks 1-3 was measured. An observed change in BSA mass was used as a 
marker for extent of glycation. 
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Chapter 3  
Results and Discussion 
3.1. Determine relevant parameters for improving enantioselection     
   and migration time reproducibility 
 
 Early work focused on elucidating the enantiomeric selectivity of serum albumins 
for D- and L- tryptophan, found that the L-enantiomer of tryptophan binds to site II 
with an affinity approximately 100 times higher than that of the D-enantiomer 
(McMenamy & Oncley, 1958).  Investigations by Yang and Hage found that the D-
enantiomer interacts with site I indirectly, but has no interaction with site II (Yang & 
Hage, 1993).  The pH and ionic strength of the BGE used in this study is similar to 
that approximated under physiological conditions. The native state of the protein and 
its molecular function are preserved (Yang & Hage, 1993). Under these conditions 
optimum binding of D- and L-tryptophan to bovine serum albumin was found to 
occur (Gilpin et al., 1991). Therefore it is of importance to determine the relevant 
experimental parameters that are required for optimum enantioselectivity prior to 
carrying out further protein-drug binding investigations. 
 There is little information regarding the exact experimental conditions that are 
most relevant for improving chiral recognition by serum proteins in CE applications.  
Several factors affect the precision of measurement such as buffer viscosity, sample 
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plug length, and applied voltage.  The major challenge is the change in EOF over 
time caused by protein interactions with the inner surface of the capillary.   A 
protein’s tendency to adsorb is determined by its primary structure, structural 
stability, charge, and size (Nakanishi et al., 2001).   Protein adsorption to the capillary 
inner surface can be reduced by developing rinsing strategies. Adverse effects from 
conductivity can be minimized by using multivalent ions to prepare BGE. Phosphate 
buffers, similar to that employed in this study, have been reported to decelerate 
adsorption by stabilizing the native structure of the protein (Kurrat et al., 1997). The 
aim of this section was to determine the relevant parameters that improve 
enantioselection of D- and L-tryptophan by BSA.   
3.1.1. Ohm’s Law Plot 
 Band broadening at higher voltages is caused by Joule heating.  This heat is 
generated by collisions that occur between solute ions and electrolyte ions.  The 
extent of heating is based on the conductivity of the BGE and the voltage applied.  
Higher ionic strength buffers usually are employed to minimize ion-exchange effects 
between charged solute and ionized silanol groups on the capillary wall.  High ionic 
strength buffers can yield increased heating at constant voltage. The amount of heat 
generated using high currents may be beyond the thermostat capabilities of the CE 
instrument employed. 
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Figure 10: Ohm’s law plots showing the optimum voltage for sodium phosphate 
buffers, pH 7.4 (25- 100 mM). ACE conditions: capillary temperature 25°C. 
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 Although capillaries are cooled on the outer surface, a significant temperature 
difference between the BGE in the center and the inner capillary wall can occur 
leading to nonuniform temperature gradients within the capillary as well as localized 
changes in BGE viscosity.  The generation of heat can evaporate BGE solution.  
Therefore heat dissipation should be efficient to avoid these adverse effects.  Thermal 
effects can be circumvented by adjusting the ionic strength of the BGE.   
 In order to determine the maximum voltage that could be applied without 
exceeding the heat removal capacity of sodium phosphate buffers ranging in 
concentration from 25 – 100 mM, an Ohm’s law plot was constructed, as illustrated in 
Figure 10. Each set of data was fitted by linear regression as represented by the 
dashed lines.  The regression coefficients for the 25 mM, 50 mM, 75 mM, and 100 
mM buffers were 0.996, 0.987, 0.970, and 0.951, respectively.  Linearity in the plot 
was an indication that the generated heat was being adequately dissipated and 
capillary temperature was maintained. Deviation from linearity was an indication that 
the thermostatting capability of the system had been exceeded.   Linearity was lost for 
both the 75 mM and 100 mM buffers at lower applied voltages, in comparison to 
those observed for the 25 mM and 50 mM concentrations. In contrast, the 25 mM 
buffer exhibited a linear relationship between current and the applied voltage across 
the entire range of voltages studied (0- 30 kV), indicating its ability to maintain 
capillary temperature at the maximum applied voltage allowed by the instrument.   
Subsequently, the 25 mM buffer system was employed for the remaining studies. 
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3.1.2. Applied voltage effects on peak shape  
 Human serum albumin adsorption to capillary walls decreases in the presence of 
an electric field (Yang & Hage, 1994).   Mechanisms involved in separating D- and 
L- tryptophan depend upon the concentration of protein that is free floating in BGE.  
Therefore application of a separation voltage, which minimizes adsorption of protein 
to the inner walls of the capillary, will result in improved enantioselection, while 
those that do not will cause a loss in enantioselection.   
 This idea was studied by initially applying separation voltages of 10- 30 kV. 
Enantiomer peaks were not observed at applied voltages below 10 kV. Applied 
voltages >15 kV produced currents that were above 100 μA. To avoid diffusion 
caused by joule heating associated with high currents, voltages above 15 kV were not 
used in all later experiments. Electropharograms for D,L-tryptophan at separation 
voltages of 10 kV and 15 kV are illustrated in Figure 11 and Figure 12, respectively. 
Peak shape distortion was evident at voltages below 15 kV. By using a separation 
voltage of 15 kV, peak shape distortion was no longer observed and enantioselectivity 
was improved. These results indicated that the stability of absorbed BSA was highest 
in the presence of lower applied voltage.  This is the same type of behavior seen in 
earlier studies (Yang & Hage, 1994). 
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Figure 11:  Effect of applied voltage on D- and L- tryptophan separation as 
represented by peak distortion.  BSA concentration in BGE was kept at 30 μM and 
D,L-tryptophan amount used was 0.54 mg/ml. ACE conditions: 25°C, 20 mbar 
injection for 5s, detection at 280 nm,10 kV separation voltage. 
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Figure 12:  Effect of applied voltage on D- and L-tryptophan separation as 
represented by peak distortion.  BSA concentration in BGE was kept at 30 μM and 
D,L-tryptophan amount used was 0.54 mg/ml. ACE conditions: 25°C, 20 mbar 
injection for 5s, detection at 280 nm, 15 kV separation voltage. 
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3.1.3. Sodium hydroxide and water rinse effects on migration time  
 At physiological pH, both the inner capillary wall and BSA are negatively 
charged.  Protein-wall interactions primarily are due to H-bonding that occurs 
between the carbonyl and amino groups on the protein and the silanol groups on the 
capillary wall (van der Veen et al., 2004; Gray, 2004).   In albumin the average 
density of amino groups that possess H-binding capability is 0.25/nm2 (Kurrat et.al, 
1997).  Protein adsorption modifies the surface charge of the capillary, contributing to 
changes in the mobility of the EOF.  This allows for the EOF migration time to serve 
as a marker for protein adsorption (Graf et al., 2005).  Rinsing the capillary with 
additives that cleave H-bonds promotes protein desorption (Docoslis et al., 2001).   
 Capillary surface regeneration was investigated by rinsing the capillary with  
0.1 M NaOH and deionized water at variable times, followed by BGE.    
It was found that NaOH rinsing for 3 min at 920 mbar, followed by deionized water 
for 3 min at 920 mbar was most effective at controlling shifts in EOF mobility, RSD 
0.19%, (n = 4) (Figure 13). The repeatability drastically diminished as the rinse time 
increased.   
 Rinsing the capillary with excessive amounts of sodium hydroxide has been 
reported to permit successive saturation of available adsorption sites with protein 
residues (Ermakov et al., 1995), permitting protein clusters to pile up within 
consecutive runs.  Decrease in the EOF migration time repeatability was substantial 
for the 9 min rinsing protocol, RSD 12.4%, (n = 4). There was a 3 minute difference 
in the EOF migration time between the first and second injections.  The rinse time 
was increased to 12 minutes and there was an improvement in repeatability,  
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RSD 2.4% ( n=4), but repeatability remained lower than that for the 3 min rinsing 
protocol.  A 3 min rinsing protocol was used in subsequent studies.  
 The NaOH and water regime was further investigated by rinsing for 3 min with 
and without 0.1M NaOH and deionized water between consecutive injections.  Each 
run included a rinse with BGE only.  It was found that the RSD improved from 24.7% 
without NaOH- water rinse to 1.84% ( n = 4) with NaOH-water rinse, indicating an 
improvement in precision due to the removal of protein from the capillary wall. 
Omission of NaOH-water rinsing, led to inverted peaks in the electropharogram 
indicating the protein had a higher absorbance at the detection window than D, L-
tryptophan (Figure 14).  These results indicated that the implementation of a 3 min 
rinsing protocol was best for stabilizing the EOF of successive separations. 
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Figure 13: The effect of sodium hydroxide/water rinse time on the repeatability of 
acetone (neutral marker) migration time in the presence of 30 μM BSA. ACE 
conditions: 25°C, 20 mbar injection for 5s, detection at 280 nm, 15 kV separation 
voltage. 
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Figure 14: D,L-tryptophan  (0.54 mg/ml). ACE conditions: 25 mM sodium 
phosphate, pH 7.4, 30 µM  BSA,  25°C, 20 mbar injection for 5s, 15 kV, detection at 
280 nm. 0 min NaOH-water rinse between injections. Electropharogram obtained 
directly from ChemStation software (Agilent, Waldbronn, Germany) without further 
data processing.  
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3.1.4. Evaluating selectivity as a function of BGE rinse time 
 To examine how the inherent tendency of proteins to absorb onto the capillary 
wall affects enantioselectivity of tryptophan by BSA, the capillary was rinsed with 
BGE for 6 – 32 minutes using 920 mbar pressure. Representative electropharograms 
are shown in Figures 15 – 18, for 8, 16, 24, and 32 minute rinse protocols, 
respectively.  Selectivity, α, was calculated as a function of BGE rinse time for four 
separate injections.  Subsequently, a plot of the average selectivity versus BGE rinse 
time was made (Figure 19) and fitted using a fourth-order polynomial, which yielded 
a regression coefficient of 1.  The first-derivative curve of the selectivity with respect 
to BGE rinse time was plotted and appears in Figure 20.   
 The average selectivity (n = 4) for the 6 min, 8 min, 16 min, 24 min, and 32 min 
rinse times were 2100.1  , 2102.1  ,  3103.8  , 3104.1  , and 0, respectively. 
Based upon the amount of protein adsorbed, a non-uniform distribution of the ζ-
potential along the capillary occurred (Ren & Li, 2001).  Differences in the ζ-
potential led to changes in the EOF mobility thereby diminishing selectivity.  To 
determine if the EOF mobility increased between rinsing protocols, the mobility of 
acetone (neutral marker) was measured at each rinse time. Increase in the EOF 
mobility was observed (Figure 21). These results were consistent with changes in the 
charge density on the surface of the capillary. Dissolved ions in the diffuse layer 
moved at a different velocity between each rinsing protocol (refer to Figure 3). 
 69
   
 
 
 
 
 
 
 
 
 
Figure 15: Electropharogram of D, L- tryptophan (0.54 mg/ml) separation after 
rinsing the capillary for 8 min with BGE prior to applying the voltage. ACE 
conditions: 25 mM sodium phosphate, pH 7.4, 30 µM  BSA,  25°C, 20 mbar injection 
for 5s, 15 kV, detection at 280 nm. 
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Figure 16: Electropharogram of D, L- tryptophan (0.54 mg/ml) separation after 
rinsing the capillary for 16 min with BGE prior to applying the voltage. ACE 
conditions: 25 mM sodium phosphate, pH 7.4, 30 µM  BSA,  25°C, 20 mbar injection 
for 5s, 15 kV, detection at 280 nm. 
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Figure 17: Electropharogram of D, L- tryptophan (0.54mg/ml) after rinsing the 
capillary for 24 min with BGE prior to applying the voltage. ACE conditions: 25 mM 
sodium phosphate, pH 7.4, 30 µM  BSA,  25°C, 20 mbar injection for 5s, 15 kV, 
detection at 280 nm. 
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Figure 18:  Electropharogram of D, L- tryptophan (0.54mg/ml) after rinsing the 
capillary for 32 min with BGE prior to applying the voltage. ACE conditions: 25 mM 
sodium phosphate, pH 7.4, 30 µM  BSA,  25°C, 20 mbar injection for 5s, 15 kV, 
detection at 280 nm. 
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Figure 19: Selectivity versus BGE rinse time. ACE conditions: 25 mM sodium 
phosphate, pH 7.4, 30 µM BSA,  25°C, 20 mbar injection for 5s, 15 kV, detection at 
280 nm. Equation of the 4th order polynomial fitting (solid line): y = -1.6044E-07x4 + 
1.5587E-05x3 - 5.1466E-04x2 + 6.1121E-03x - 1.1095E-02, R2 = 1.
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Figure 20: First derivative of selectivity as a function of BGE rinse time. 
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Figure 21:  Electroosmotic flow rate as a function of BGE rinse time, measured by 
the mobility of acetone. 
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 Resolution diminished in cases where the EOF was too fast, due to the solute’s 
inability to stack into uniformed zones within the capillary (Towns & Regnier, 1992; 
Tran et al., 2005).  Increased concentrations of protein in the capillary promote 
environments for protein aggregation, thus leading to dispersion within the sample 
plug (Malmsten, 1998; Ding et al., 2005; Herr et al., 2000).  The effects of rinsing the 
capillary with the BGE for a duration less than or equal to 8 minutes were negligible 
on selectivity.  Subsequently, remaining experiments were carried out rinsing the 
capillary for 8 minutes. 
3.1.5. Evaluating selectivity as a function of wait time  
 Prior to adsorption, proteins approach solvent regions directly adjacent to the 
inner surface of the capillary (Towns & Regnier, 1992). Based upon theory, the 
selectivity is expected to diminish with increased BGE rinsing time.  However, the 8 
min rinsing protocol gave the maximum selectivity not the 6 min rinsing protocol. To 
gather an understanding of this process and determine the effects of protein diffusion 
on selectivity, following the 8 minute capillary flush with BGE, a wait step was 
inserted into the rinsing protocol.  During this wait step, the BGE was left at a 
standstill in the capillary for 10- 60 minutes prior to the application of voltage. 
Representative electropharograms are shown in Figures 22– 24, for 10, 40, and 60 
minute wait periods, respectively.   
 Selectivity was calculated as a function of wait time for four separate injections.  
Subsequently, a plot of the average selectivity versus wait time was made (Figure 25) 
and fitted using a fourth-order polynomial, which yielded a regression coefficient of 
1.  The first-derivative curve of the selectivity with respect to wait time was plotted 
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and appears in Figure 26.  The average selectivity (n = 4) for the 10 min, 20 min, 30 
min, 40 min, and 60 min wait times were 2108.2  , 2104.2  , 2109.1  , 2101.1  , 
and 2100.1  , respectively.  
 It is assumed that upon initial filling of the capillary, the concentration of charged 
ions in the BGE (i.e. protein) is much higher in the center of the capillary, than near 
the wall. During the wait step, charged ions in the BGE diffuse from the region of 
high concentration in the center of the capillary, to regions of lower concentration 
towards the wall.  Since the chiral recognition of tryptophan decreases as the 
concentration of serum protein at the wall increases, enantioselection changes can 
serve as a marker for protein diffusion (Yang & Hage, 1994).  
 A pronounced decrease in selectivity was observed as a function of wait time.  
The effects of protein diffusing away from the central portion of the capillary further 
supported that observed with BGE rinse time. Differences in the ζ-potential along the 
capillary that occurred as the concentration of protein at the wall increased led to 
changes in the EOF mobility that diminished selectivity.   
 The fore mentioned results indicated that protein diffusion should be limited in 
the capillary prior to separation. It was expected that wait times below 10 minutes 
would result in higher selectivity. The 2103.2  (n = 4) average selectivity measured 
without a wait step was 16% lower than the 10 min wait step selectivity. This 
suggested that controlled protein diffusion could improve chiral recognition.  A 10 
minute wait step was incorporated into subsequent rinsing protocols.  
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Figure 22: 10 minute wait. D,L-tryptophan (0.54 mg/ml). ACE conditions: 25 mM 
sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar injection for 5s, 15 kV, 
detection at 280 nm. The capillary was rinsed for 8 minutes with background 
electrolyte solution prior to wait period. 
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Figure 23: 40 minute wait. D,L-tryptophan (0.54 mg/ml). ACE conditions: 25 mM 
sodium phosphate, pH 7.4, 30 µM  BSA,  25°C, 20 mbar injection for 5s, 15 kV, 
detection at 280 nm. The capillary was rinsed for 8 minutes with background 
electrolyte solution prior to wait period. 
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Figure 24: 60 minute wait. D,L- tryptophan (0.54 mg/ml). ACE conditions: 25 mM 
sodium phosphate, pH 7.4, 30 µM  BSA,  25°C, 20 mbar injection for 5s, 15 kV, 
detection at 280 nm. The capillary was rinsed for 8 minutes with background 
electrolyte solution prior to wait period. 
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Figure 25: Selectivity versus wait time. ACE conditions: 25 mM sodium phosphate, 
pH 7.4, 30 µM  BSA,  25°C, 20 mbar injection for 5s, 15 kV, detection at 280 nm. 
The capillary was rinsed for 8 minutes with background electrolyte solution prior to 
each wait period. The equation of the 4th order polynomial fitting (solid line):  
y = 1.3287E-08x4 - 1.1936E-06x3 + 2.6123E-05x2 - 4.7843E-04x + 3.0905E-02,  
R2 = 1. 
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Figure 26: First derivative of selectivity as a function of wait time. 
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3.1.6. Evaluating selectivity as a function of sample buffer ionic strength 
 The voltage along the capillary is assumed to be constant, when it is filled only 
with BGE.  When solutes of different mobilities are drawn into the capillary, the 
solutes will separate into zones, according to their relative mobilities (Equation 5).  
Each of these solute zones is surrounded by a zone of BGE, and the voltage along the 
capillary is no longer constant.  According to circuit theory, where  
                                   V = IR                                                                          (16) 
and V is the applied voltage, I is the current, and R is the resistance, conductivity 
differences between zones will determine the magnitude of voltage experienced in 
that zone. The voltage will be low in zones of high mobility solute and high in zones 
of low mobility solute.  The local field strength described by: 
 
                                    V/L                                                                              (17) 
where V is the applied voltage and L is the total length of the capillary, will therefore 
be different in the solute zone based upon the mobility.  Changes in the local field 
strength with respect to that of the surrounding BGE can lead to diffusion through 
electromigration dispersion (Swedberg, 1990).  The effects of electrodispersion can 
be minimized by decreasing the mobility difference between that of the solute and the 
BGE ions.  This can be carried out by adjusting the concentration of the BGE, of the 
sample buffer, or both. Increasing the concentration of the BGE can lead to band 
broadening due to Joule heating if the conductivity of the BGE is high. For this 
reason, only the effect of the sample buffer concentration was examined in this 
section. 
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 Tryptophan samples were prepared in sodium phosphate buffer, pH 7.4, at a 
concentration of 5 – 25 mM.   The effects of electrodispersion were assessed by 
measuring the selectivity as a function of sample buffer ionic strength for four 
separate injections.  Representative electropharograms are shown in Figures 27-30, 
for the 5 mM, 8 mM, 15 mM, and 25 mM sample buffer concentrations, respectively.  
Subsequently, a plot of the average selectivity versus sample buffer ionic strength 
was made (Figure 31) and fitted using a third-order polynomial, which yielded a 
regression coefficient of 1.  The first-derivative curve of the selectivity with respect to 
sample buffer ionic strength was plotted and appears in Figure 32. The average 
selectivity (n = 4) for the 5 mM, 8 mM, 15 mM, and 25 mM concentrations were 
31095.9  , 21003.1  , 21003.1  , and 31074.8  , respectively. 
 The slope of the first derivative plot indicated that the enantioselection decreased 
as the sample buffer concentration increased, suggesting the difference in the 
mobilities of tryptophan and the BGE increased with buffer concentration. The 
maximum average selectivity was the same for samples prepared in 8 mM and 15 
mM sodium phosphate. Although these values were the same, the RSD between 
consecutive injections was 0.03 for the samples prepared in the 8 mM buffer and 0.24 
for the samples prepared in the 15 mM buffer. This indicated the variability in 
electrophoretic mobility was higher between consecutive injections for samples 
prepared in the 15 mM buffer. This also suggested higher variability between the 
sample plug mobility and the BGE mobility when samples were prepared in 15 mM 
sodium phosphate.  Therefore the 15 mM buffer was not employed in subsequent 
studies. 
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Figure 27: D,L-tryptophan (0.54mg/ml) prepared in 5 mM sodium phosphate, pH 
7.4.  ACE conditions: 25 mM sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar 
injection for 5s, 15 kV, detection at 280 nm. 
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Figure 27. 
 
 
 
 
t-teof  (min)
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
A
bs
or
ba
nc
e 
(A
u)
 
L
 D → 
 99
 
 
 
 
 
 
 
 
 
 
Figure 28: D,L-tryptophan (0.54mg/ml) prepared in 8 mM sodium phosphate, pH 
7.4.  ACE conditions: 25 mM sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar 
injection for 5s, 15 kV, detection at 280 nm. 
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Figure 28. 
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Figure 29: D, L-tryptophan (0.54mg/ml) prepared in 15 mM sodium phosphate, pH 
7.4.  ACE conditions: 25 mM sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar 
injection for 5s, 15 kV, detection at 280 nm. 
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Figure 29. 
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Figure 30: D,L-tryptophan (0.54mg/ml) prepared in 25 mM sodium phosphate, pH 
7.4.  ACE conditions: 25 mM sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar 
injection for 5s, 15 kV, detection at 280 nm. 
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Figure 30. 
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Figure 31: Selectivity versus sample buffer concentration. ACE conditions: 25 mM 
sodium phosphate, pH 7.4, 30 µM BSA, 25°C, 20 mbar injection for 5s, 15 kV, 
detection at 280 nm. The equation of the 3rd order polynomial fitting (solid line):   
y = 9.7225E-08x3 - 1.4028E-05x2 + 2.8471E-04x + 8.8652E-03, R2 = 1. 
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Figure 31. 
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Figure 32: First derivative of selectivity as a function of sample buffer concentration 
(mM). 
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Figure 32. 
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 Electrodispersion caused by mismatched solute and BGE mobility will lead to 
detected peak tailing or fronting as a result of the solute moving slower or faster than 
the bulk liquid, respectively.  The shape of the detected peaks at both the 5 mM and 8 
mM sample concentrations presented peak tailing, which suggested that the 
tryptophan zone was moving slower than the BGE; however the extent of tailing at 8 
mM was less than that observed at 5 mM.  This indicated that the conductivity in the 
sample zone increased with ionic strength, and caused the tryptophan ions to migrate 
faster in the capillary.   
 The effect of electrodispersion on enantioselection was negligible when the 
concentration of the sample buffer was no more than three orders of magnitude lower 
than the BGE 25 mM concentration.  This was in agreement with previously reported 
studies (Bruin et al., 1989). As a result, subsequent studies were carried out using 
samples prepared in 8 mM sodium phosphate, pH 7.4. 
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3.2. Capillary electrophoresis applications for studying 
       competitive binding 
 
3.2.1. Determining sample concentration 
 In CE both the protein and the protein-drug complex are under a voltage current 
that may change their shapes, leading to the generation of new binding sites or 
modification of existing binding sites. As a result, the optimized conditions from 
section 3.1 were retested on a new capillary and a BSA concentration of 35 μM in the 
BGE improved baseline separation. Therefore it was used in subsequent experiments. 
  In studies using CE it is assumed that the solute’s mobility is independent of the 
solute’s initial sample concentration (Bose et al., 1997; Yang et al., 1996; El-Hady, et 
al., 2010).  As shown in Figure 33 for tryptophan (Tryp) and 5- fluoro-tryptophan, the 
mobility shift of the L-enantiomer initially increases as the concentration of drug is 
increased. A noticeable change in mobility occurred at concentrations greater than 0.9 
mg/ml. This suggests that tryptophan concentrations within the range of 0.1 mg/ml 
and 0.9 mg/ml can be used for binding studies.  As a result of the D-enantiomer not 
forming a drug-protein complex with BSA, its mobility shift for both drug molecules 
was essentially unchanged. 
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Figure 33:  Mobility shifts of D,L-tryptophan and 5-fluoro-D,L-tryptophan as a 
function of  tryptophan and 5-fluoro-tryptophan concentrations, respectively. For both 
(a) D ( ), L ( )-tryptophan and (b) 5-fluoro-D( ), L ( )-tryptophan the 
concentration of BSA in the background electrolyte was held constant at 35 µM and 
the sample concentrations employed were 0.1, 0.2, 0.4, 0.9, 1.3, 2.2, and 2.6 (mg/ml). 
ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm. 
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Figure 33. 
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 These observed results can be elucidated by assuming a 1:1 drug-protein complex 
model. In isotropic conditions enantiomers exhibit the same behavior. The key factor 
required for enantiomeric separation is the presence of a protein chiral selector in the 
BGE. Representative electropharograms of D,L-tryptophan and 5-fluoro-D,L-
tryptophan in BGE void of BSA are shown in Figures 34 and 35, respectively. Under 
conditions in which enantiomer-protein interaction is blocked separation will not 
occur.  As the concentration of drug injected into the capillary is increased, the 
number of drug saturated protein molecules also increases occupying all available 
binding sites. Concentrations above optimum range result in non-linear isotherm 
conditions that adversely affect separation efficiency. 
 Separations under nonlinear isotherm condition will produce changes in the 
mobility shift, leading to diminished baseline resolution, and distortion of the binding 
enantiomer peak shape as represented in Figure 36 for D,L-tryptophan.  The D-
enantiomer peak maintains its Gaussian shape, while the L-enantiomer peak tails. To 
maintain continuity between drug samples and utilize drug concentrations that would 
not adversely affect the precision of CE measurements, 0.22 mg/ml (1 mM) was 
employed for subsequent studies. The final molar ratio of tryptophan:BSA in the 
capillary for subsequent studies was 1:4.   
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Figure 34:  D,L-tryptophan, 0.22 mg/ml (1mM),  run in 25 mM sodium phosphate,  
pH 7.4, void of BSA. ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and 
detection at 280 nm. 
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Figure 34. 
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Figure 35:  5-fluoro-D,L-tryptophan, 0.22 mg/ml (1mM), run in 25 mM sodium 
phosphate, pH 7.4, void of BSA. ACE conditions: 15 kV, 25°C, injection at 20 mbar 
for 5 s, and detection at 280 nm. 
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Figure 35. 
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Figure 36:  Changes in peak shape due to nonlinear isotherm conditions. BSA 
concentration was held to 35 μM. D,L-tryptophan sample concentrations  used were 
0.1 mg/ml, 0.4 mg/ml, and 0.9 mg/ml. ACE conditions: 15 kV, 25°C, injection at 20 
mbar for 5 s, and detection at 280 nm. 
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3.2.2. Separation selectivity in the presence of ibuprofen 
 
 Differences in enantiomer affinity for a given phase are measured by 
selectivity 




1
2
k
k . The variables k2 and k1 are the retention factors for enantiomer 2 
and enantiomer 1, respectively. The separation selectivity can be well characterized 
with the relative mobility difference between enantiomers by Eq.11 (Chankvetadze, 
1997; Blaschke & Chankvetadze, 2003). 
 In initial experiments selectivity was measured in BGE void ibuprofen. As 
reported in literature, the selectivity of BSA for 5-fluoro-D,L-tryptophan was 
approximately two times greater than that for D,L-tryptophan, 2104.3   (n = 4) 
and 2106.1  (n = 4), respectively (Tittlebach & Gilpin, 1995).  The higher selectivity 
of 5-fluoro-D,L-tryptophan can be ascribed to differences in hydrophobicity between 
derivatives. It was also reported that 5-fluoro-tryptophan has two chemically distinct 
binding sites on serum albumin (Gerig & Klinkenborg, 1980).  The displacement of 
tryptophan was studied by determining the selectivity value for tryptophan derivatives 
in the presence of ibuprofen in the BGE. Ibuprofen was added to the BGE at 
concentrations of 5.5 μM, 22.1 μM , 33.2 μM, 44.2 μM , and 55.3 μM . These 
concentrations resulted in displacer:BSA molar ratios of 1:6, 1:1.6, 1:1, 1.3:1, and 
1.6:1, respectively.  The selectivity decreased initially for both derivatives, until the 
displacer:BSA molar ratio reached 1:1, Figure 37. 
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Figure 37: Separation selectivity of BSA for 5-fluoro-D,L-tryptophan ( ) and  
D,L-tryptophan ( ) as a function of ibuprofen [Ibu] concentration in the background 
electrolyte. Serum protein concentration was held at 35 μM. The concentration of 
ibuprofen added to the background electrolyte was 0, 5.5, 22.1, 33.2, 44.2, and 55.3 
μM, respectively. ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and 
detection at 280 nm. The standard error in the selectivity is shown for each individual 
concentration of ibuprofen. 
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 The change in selectivity, defined as the difference between the highest and 
lowest calculated selectivity value, for D,L-tryptophan was 3102.8   and 5-fluoro-
D,L-tryptophan 3104.6  . At molar ratios in which BSA was in excess, ibuprofen 
appeared to bind mainly to its primary sites on the protein. Diminished selectivity 
under these conditions showed that the presence of ibuprofen blocked BSA from 
binding L-tryptophan. Representative electropharograms are shown in Figures 38 and 
39 for D,L-tryptophan and 5-fluoro-D,L-tryptophan both with 22 μM ibuprofen in the 
BGE.  Baseline separation was still observed for 5-fluoro-D,L-tryptophan. This 
suggested that the affinity of 5-fluoro-D,L-tryptophan binding to BSA was higher 
than that for D,L-tryptophan. The binding constants were measured for each analog. 
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Figure 38:  Electropharogram of  D,L-tryptophan (0.22 mg/ml) at a ibuprofen:BSA 
molar ratio of 1.6:1 (22 μM ibuprofen). The serum protein concentration was held at 
35 μM. ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 
280 nm. 
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Figure 38. 
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Figure 39:  Electropharogram of 5-fluoro-D,L-tryptophan at a ibuprofen:BSA molar 
ratio of 1.6:1 (22 μM ibuprofen). The serum protein concentration was held at 35 μM. 
ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm. 
 127
 
 
Figure 39. 
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3.2.3. Measuring the binding constant 
 These observed differences in binding between analogs were elucidated by 
assuming a 1:1 drug-protein complex model, 
                                             E + P 
aK
  EP                                                       (17)                               
                                               PE
EPK a                                                     (18)                                   
where aK , [E], [P], and [EP], denote the association constant, and the molar 
concentrations of drug, protein, and drug-protein complex, respectively.  
In this model, the effective mobility of the drug, eff , is described as                     
 
   
 
    


 







 




 EPEEPEPEEeff EPE
EP
EPE
E       (19)                                  
The mobility of free ( E ) and bound ( EP ) drug is weighted by their molar fractions 
)( .   The capacity factor, referred to as the retention factor in some cases, describes 
the ratio of bound to free drug.  The retention factor, k, is mathematically defined by 
(Ostergaard, 2007):  
                            ]P[K]E[
]EP[k a
0E
EEP 
                            (20)                                
where μEP, μE, and μ0, are the mobilities of the bound drug, the free drug, and the drug 
without protein in the BGE.  From Equation 20, the binding constant can be 
experimentally determined.  In this study, the mobilities of the L-enantiomer and the 
D-enantiomer were used to measure μEP and μE, respectively. The retention factors for 
5-fluoro-D,L-tryptophan and D,L-tryptophan were measured in a BSA concentration 
range of 10 – 35 μM. 
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Figure 40: Binding constant estimates for 5-fluoro-D,L-tryptophan and D,L-
tryptophan to BSA (10- 35 μM). (a) Retention factor versus BSA concentration 
binding plot for 5-fluoro-tryptophan. Equation of the linear fitting: y = 523.14x + 
.0013, R2 = 0.95; (b) Retention factor versus BSA concentration binding plot for 
tryptophan. Equation of the linear fitting: y = 198.84x + 0.0019, R2 = 0.93. 
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 The binding constant of 5-fluoro-tryptophan with BSA was 523.14 μM-1  with a 
correlation coefficient of 0.95. The binding constant of tryptophan with BSA was 
198.84 μM-1 with a correlation coefficient of 0.93. Plots are shown in Figure 40. The 
results demonstrated that 5-fluoro-tryptophan had a larger affinity to serum albumin 
than that of tryptophan. Thus the difference in selectivity of BSA for 5-fluoro-D,L- 
tryptophan and D,L-tryptophan in the presence of ibuprofen was due to the higher 
binding affinity of the fluoro-analog.  
 The binding constant determined for L-tryptophan from the CE method agreed 
with the value of a previous NMR study under similar experimental conditions 
reported to be 230 ± 90 μM-1 (Fielding et al., 2005). Differences in buffer ionic 
strength and temperature fluctuation, may have contributed to the wide range of 
values reported across laboratories for tryptophan-BSA binding studies. 
 
3.2.4. Measuring selectivity by preformed displacer-protein binary complexes  
 
 With the protein free floating in solution, drug-protein interaction is variable. 
Such conditions may require higher levels of displacer before effects are observed. 
Separations with preformed displacer-protein complexes provide a direct approach to 
characterize drug-drug displacement (Li et al., 2011). In a separate experiment using 
D,L-tryptophan because of its marked change in selectivity, ibuprofen was 
equilibrated with BSA at a displacer:BSA molar ratio of  1:7 for two hours and 4 .5 
hours before measurements were taken to establish preformed ibuprofen-BSA binary 
complexes in the BGE.  
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3. 3. Capillary electrophoresis applications for studying binding  
          of glycated serum proteins. 
 
3.3.1. Characterization of extent of glycation 
Capillary Electrophoresis 
 Capillary electrophoretic analysis of intact BSA in sodium phosphate buffer, pH 
7.4 offered an incomplete separation of modified proteins. The incomplete separation 
could have been caused by proteins sticking to the capillary wall. At physiological 
pH, protein absorption to the capillary may be pronounced (Graf et al., 2005). 
Modification of BSA by glucose rearranged the separation profile, such that the 
number of peaks increased over time (Figure 41). The presence of these peaks in the 
electropharogram suggested there were a variety of new products forming during the 
modification process. The number of new products formed increased with incubation 
time.   
Mass Spectrometry 
 To test the applicability of the capillary electrophoretic data, the mass was 
evaluated for unmodified and modified BSA.   The molecular weight of the 
unmodified BSA was found to be approximately 66, 438 Da. Consistent with 
previous reports, the masses of modified BSA derived from incubation with glucose 
were found to increase with increasing incubation time (Schmitt, et al., 2005). 
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Figure 41: CE/UV peak profiles of unmodified and modified BSA in 25 mM sodium 
phosphate at pH 7.4.  Unmodified BSA (A), BSA modified by glucose for 1 week 
(B), BSA modified by glucose for 2 weeks (C), BSA modified by glucose for 3 weeks 
(D).  All incubations were carried out at 25°C. ACE conditions: 25°C, 20 mbar 
injection for 5s, 15 kV, detection at 280 nm.  
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 The highest mass of BSA was measured for the 3 week glucose incubation.  The 
data from the electrophoretic characterization earlier were supported by the mass 
spectrometric results.  The increase in molecular weight induced by glycation 
corresponds to the attachment of glucose units to the amino residues of the protein 
(Rondeau & Bourdon, 2011).   The number of glucose units bound to the protein was 
deduced from the mass difference between the unmodified and modified protein.  The 
maximum number of glucose units added after one, two and three weeks of 
incubation were 9, 70, and 76, respectively.  The masses of all protein samples for 
weeks 1 – 3, along with the approximate number of glucose molecules added to each 
newly glycated BSA are given in Tables I- III. 
Nuclear Magnetic Resonance 
 The 1H-NMR spectrum of unmodified BSA showed no peaks in the spectral 
region at ~ 5.0 to 5.55 ppm studied.  The 1H –NMR of modified BSA incubated for 3 
weeks in D-glucose consisted of an envelope of peaks. Notable were the resolved 
doublets at 5.24 ppm and 5.50 ppm.  Based on the available data in the literature  
( Bubb, 2003; Cui et al., 2007),  the resonance at 5.24 ppm was attributed  to proton-
proton (JHH) coupling in free α-glucose.  There was a large amount of free glucose in 
the sample, which resulted in the signal going off scale in the plot.  From this large 
amount of free glucose two Carbon-13 satellite signals on either side of this main 
peak were observed, whose combined intensities were 1.1 % of the main peak. The 
resonance from the 1H-NMR spectrum at 5.50 ppm indicated glucose was linked to 
BSA through a glycosidic bond (Figure 42) (Bao et al., 2012). This verified protein 
structural modification.  
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Table I: Data from mass spectrometric analysis of unmodified and modified BSA 
after a 1 week incubation in 14 mM D-glucose at 25°C. The modified BSA with the 
highest number of glucose molecules bound is highlighted.  The concentration of 
BSA was 35 μM. 
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Table I. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mass 
BSA 
Mass of 
Glycated 
BSA 
Mass 
Difference
Added 
Glucose 
Molecules 
66438 66755 317 2 
 66888 450 2 
 67674 1236 7 
 67080 642 4 
 67703 1265 7 
 67871 1433 8 
 67399 961 5 
 68094 1656 9 
 67387 949 5 
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Table II: Data from mass spectrometric analysis of unmodified and modified BSA 
after a 2 week incubation in 14 mM D-glucose at 25°C. The modified BSA with the 
highest number of glucose molecules bound is highlighted.  The concentration of 
BSA was 35 μM. 
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Table II. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mass 
BSA 
Mass of 
Glycated 
BSA 
Mass 
Difference 
Added 
Glucose 
Molecules 
66438 66755 317 2 
 78808 12370 69 
 66888 450 2 
 76135 9697 54 
 69294 2856 16 
 79132 12694 70 
 72732 6294 35 
 67674 1236 7 
 78212 11774 65 
 74747 8309 46 
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Table III: Data from mass spectrometric analysis of unmodified BSA and modified 
BSA after a 3 week incubation in 14 mM D-glucose at 25°C. The modified BSA with 
the highest number of glucose molecules bound is highlighted.  The concentration of 
BSA was 35 μM. 
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Table III. 
 
Mass 
BSA 
Mass of 
Glycated 
BSA 
Mass 
Difference 
Added 
Glucose 
Molecules 
66438 66600 162 1 
 80067 13629 76 
 70930 4492 25 
 67760 1322 7 
 71409 4971 28 
 78433 11995 67 
 75313 8875 49 
 80134 13696 76 
 74435 7997 44 
 66755 317 2 
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Figure 42: This is a plot of the spectral region at ~ 5.0 – 5.55 ppm showing signals 
from the H1 proton (shown in red) on α-D-glucose. The red spectrum is that of the 
unmodified BSA (control). The black spectrum is that of modified BSA after a 3 
week incubation in 14 mM D-glucose at 25°C. 
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3.3.2. Chiral recognition of glycated BSA 
 The chiral recognition of tryptophan analogs by BSA was altered by the extent of 
glycation.  Representative electropharograms for D,L-tryptophan, 5-fluoro-D,L-
tryptophan, and 5-hydroxy-D,L-tryptophan are shown in Figures 45- 47, respectively. 
The selectivity was calculated for four separate injections of D,L- tryptophan and 5-
fluoro-D,L-tryptophan.  It was not possible to separate 5-hydroxy-D,L-tryptophan by 
unmodified or modified BSA as previously reported (Hödl et al., 2006).  As a result, 
the changes in the 5-hydroxy-D,L-tryptophan peak area were measured for 
subsequent weeks and used to approximate changes in its chiral recognition by BSA 
as follows: 
                                         100Area
Area
n
1n 



                                            (21) 
where n denotes the week(s) of incubation in D-glucose solution.  
 Glycation of BSA altered the chiral recognition of D,L-tryptophan, 5-fluoro-D,L-
tryptohan, and 5-hydroxy-D,L-tryptophan after one week.  The decline in 
enantioselection was most pronounced for D,L-tryptophan at 0.051 (Figure 45). The 
selectivity for 5-fluoro-D,L-tryptophan declined by 0.032 and the peak area of 5-
hydroxy-D,L-tryptophan decreased by 13.4%  (Figure 47, 49).  The chiral recognition 
continued to decline after week 2 for both D,L-tryptophan and 5-hydroxy-D,L-
tryptophan, however that of 5-fluoro-D,L-tryptophan increased. Although the trend in 
decreased enantioselection reversed for all analogs after three weeks, chiral 
recognition did not return to its starting values, (Figures 46, 48, and 50). 
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Figure 43: D,L-tryptophan (0.22 mg/ml) binding by unmodified BSA (A) and 1 week 
modified BSA (B).  The serum protein concentration was held at 35 μM. ACE 
conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm. 
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Figure 43. 
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Figure 44: D,L-tryptophan (0.22 mg/ml) binding by 2 week modified BSA (A) and 3 
week modified BSA (B).  The serum protein concentration was held at 35 μM. ACE 
conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm. 
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Figure 45: 5-fluoro-D,L-tryptophan (0.22 mg/ml) binding by unmodified BSA (A) 
and 1 week modified BSA (B).  The serum protein concentration was held at 35 μM. 
ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm. 
 
 
 
 
 
 
 
 
 150
 
Figure 45. 
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Figure 46: 5-fluoro-D,L-tryptophan (0.22 mg/ml) binding by 2 week modified BSA 
(A) and 3 week modified BSA (B).  The serum protein concentration was held at 35 
μM. ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 
nm. 
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Figure 46.  
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Figure 47: 5-hydroxy-D,L-tryptophan (0.22 mg/ml) binding by unmodified BSA (A) 
and 1 week modified BSA (B).  The serum protein concentration was held at 35 μM. 
ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm. 
 154
Figure 47. 
 
 
 
A 
B 
 155
 
 
 
 
 
 
 
 
 
 
 
Figure 48: 5-hydroxy-D,L-tryptophan (0.22 mg/ml) binding by 2 week modified 
BSA (A) and 3 week modified BSA (B).  The serum protein concentration was held 
at 35 μM. ACE conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 
280 nm. 
 156
Figure 48. 
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Figure 49:  Effect of glycation extent on BSA selectivity of   
D,L-tryptophan.  The serum protein concentration was held at 35 μM. ACE 
conditions: 15 kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm. 
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Figure 49. 
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Figure 50:  Effect of glycation extent on BSA selectivity of 5-fluoro-D,L-tryptophan.  
The serum protein concentration was held at 35 μM. ACE conditions: 15 kV, 25°C, 
injection at 20 mbar for 5 s, and detection at 280 nm. 
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Figure 50. 
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Figure 51:  Effect of glycation extent on BSA selectivity of 5-hydroxy-D,L-
tryptophan.  The serum protein concentration was held at 35 μM. ACE conditions: 15 
kV, 25°C, injection at 20 mbar for 5 s, and detection at 280 nm. 
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 The results indicate that albumin functional properties are impacted by glycation-
induced modifications of its structure.   Some of the main glycation sites are located 
in the vicinity of known drug binding sites (Wa et al., 2007).  The extent of glycation 
depends upon the time of incubation and in periods of less than 10 days, early stage 
glycation products that arise from Schiff base reactions occur in the central body of 
the protein (Cohen, 2003; Schmitt et al., 2005; Coussons et al., 1997).  The latter 
stages of glycation occur on the C- and N- terminal regions causing the body of the 
protein to be effected by glycation first.  The L-tryptophan binding site (site II) is 
located in a hydrophobic cleft between two predominant helical structures in the body 
of the protein (Peyrin et al., 1999; Kragh-Hansen et al., 2001).  Any changes in the 
helical arrangement of BSA induced by the glycation process will alter its binding, 
which correlates to shifts in enantioselection of tryptophan.  
 Based upon this, a postulated explanation for the observed fluctuations in 
enantioselection is that the glycation induced by incubating BSA in D-glucose for two 
weeks, reduced the helical stability of BSA and led to a decreased binding of L-
tryptophan.  An earlier study showed that low levels of glucose partially denatured 
the protein and decreased the degree of L-tryptophan binding (Barzegar et al., 2007) 
supporting the results.  The effects of this structural change on binding, were not 
observed in the case of 5-fluoro-D,L-tryptophan due to its higher binding affinity for 
BSA.  By allowing the BSA to incubate in D-glucose solution for 3 weeks, binding 
affinity of tryptophan recovered, suggesting further glycation enhanced the helical 
stability of BSA.  Previous studies by equilibrium dialysis have shown stabilization of 
the protein’s structure occurs when high concentrations of glucose are present on the 
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protein (Bohney & Feldhoff, 1992). Further support of these results, is BSA 
incubated in high concentrations of glucose have been reported to exhibit similar 
binding properties to unmodified BSA (Bohney & Feldhoff, 1992). The recovery of 
binding by BSA observed after 3 weeks of incubation in D-glucose may be attributed 
to this stabilization. Further structural studies will need to be carried out to verify 
these postulated conclusions. 
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Chapter 4 
 
Conclusion and Future Studies 
 
4.1. Summary  
 In this dissertation a satisfactory capillary electrophoresis method using protein 
CSPs for enantiomer separation was developed. In the first section of this dissertation, 
the influences of separation voltage, surface regeneration protocols using sodium 
hydroxide/water, background electrolyte rinsing time, sample buffer ionic strength, 
and protein diffusion were studied.  In doing this, the tryptophan-albumin system was 
used as a model at a pH, temperature, and ionic strength optimal for BSA binding.  
The results indicate that accurate binding measurements are obtained not only by 
assuring the conditions of the microenvironment are conducive for protein binding, 
but also by optimizing relevant experimental conditions of the capillary 
electrophoresis instrument. Also from this study, it was determined that unlike 
previously proposed, allowing the liquid to stand still in the capillary prior to 
separation, does not adversely effect separation, but can enhance separation.  Future 
protein diffusion studies aimed at characterizing this relationship should be carried 
out to gain a better understanding of the mechanisms involved. 
 In the last two sections of this work, it was demonstrated that CE can be applied 
for studying biochemical processes.  It presents itself as both a means for developing 
serum albumin based selective analysis techniques and a convenient approach for 
 166
characterizing the molecular interactions of protein with drugs. In its use for studying 
the displacement of tryptophan by ibuprofen, it was found that possible preformed 
ibuprofen-BSA complexes may have altered binding and thereby introduce error in 
binding measurements.  Future studies, that incorporate steps for controlling or 
normalizing for these contributions, would be of value for calculating accurate 
binding constants.  
 In the last section, it was indicated by differences in the chiral recognition of  
non-glycated BSA and BSA glycated at various degrees, that NMR affirmed 
structural change on BSA led to alterations in its binding of tryptophan.  
Conformational and functional changes of BSA depend upon the amount of glycation. 
A better understanding of the differences in binding is possible through more detailed 
structural studies. 
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APPENDIX 
 
List of Abbreviations 
API                                               Active Pharmaceutical Ingredients 
ACE                                             Affinity Capillary Electrophoresis 
CE                                                Capillary Electrophoresis 
NMR                                            Nuclear Magnetic Resonance 
EOF                                             Electroosmotic Flow 
CSPs                                            Chiral Stationary Phases 
HSA                                             Human Serum Albumin 
BSA                                             Bovine Serum Albumin 
AGP                                             α1-acid glycoprotein 
OVM                                            Ovumocoid 
HPLC                                           High Pressure Liquid Chromatography 
BGE                                             Background Electrolyte 
SDS                                              Sodium dodecyl sulfate 
UV                                               Ultra Violet 
NaOH                                          Sodium hydroxide 
pH                                               - log[H]+ 
Trp                                               D,L-Tryptophan 
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List of Abbreviations (Continued) 
5-Flo                                            5-fluoro-D,L-tryptophan 
Ibu                                               Ibuprofen 
Au                                               Absorbance Units 
DAD                                           Diode Array Detector 
R2                                                                       Square of the correlation coefficient 
μan                                                 electrophoretic mobility of solute  
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
